SCHEMBL29137064

SCHEMBL29137064

Cc1ccnc(C2C[C@@H]2C(=O)Nc2cc(C)nc(N)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 8/20 0.38
PRKCI P41743 1/20 0.38
ITK Q08881 1/20 0.37
NAMPT P43490 3/20 0.37
ALDH1A1 P00352 3/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
LPAR2 Q9HBW0 1/20 0.36
CYP3A4 P08684 1/20 0.36
IKBKB O14920 1/20 0.35
JAK2 O60674 1/20 0.35
ROCK2 O75116 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
JAK3 P52333 1/20 0.35
ROCK1 Q13464 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29137063 1.00 MAP4K1 (0.38) MAP4K1PRKCIITKNAMPTALDH1A1
SCHEMBL29879691 0.83 MAP4K1 (0.43) MAP4K1PRKCINAMPTALDH1A1LMNA
SCHEMBL24738437 0.83 MAP4K1 (0.43) MAP4K1PRKCINAMPTALDH1A1LMNA
SCHEMBL29137062 0.75 GLA (0.41) MAP4K1ITKLMNATSHRHDAC3
SCHEMBL29137061 0.75 GLA (0.41) MAP4K1ITKLMNATSHRHDAC3
SCHEMBL30715078 0.74 CCR1 (0.40) ALDH1A1LMNASMN1; SMN2KDM4ECYP3A4
SCHEMBL29940136 0.72 TYK2 (0.41) MAP4K1ALDH1A1LMNASMN1; SMN2TYK2
SCHEMBL24737858 0.72 TYK2 (0.41) MAP4K1ALDH1A1LMNASMN1; SMN2TYK2
SCHEMBL29137012 0.72 MAPK14 (0.39) MAP4K1ITKALDH1A1LMNASMN1; SMN2
SCHEMBL29137009 0.72 MAPK14 (0.39) MAP4K1ITKALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117355521-A Heteroaryl inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-05 CN disclosed